Surge in Cannabis Hyperemesis Syndrome Cases in the U.S.

Recent data from the Centers for Disease Control and Prevention (CDC) indicates a notable rise in cases of Cannabis Hyperemesis Syndrome (CHS) among individuals seeking emergency medical care in the United States. Between October of the previous year and May of this year, diagnoses of CHS in emergency departments surged by 16%.

Understanding Cannabis Hyperemesis Syndrome

CHS primarily affects regular cannabis users and is characterized by severe, recurrent nausea, persistent vomiting, and intense abdominal pain. Prior to the introduction of a specific diagnostic code, physicians relied on a combination of codes related to vomiting and cannabis use to identify the condition. The establishment of a dedicated diagnostic code has allowed for a more accurate representation of the issue.

Emergency Room Data and Trends

Researchers analyzed data from approximately 7,500 emergency rooms across the country, recording nearly 200,000 visits associated with CHS from January 2023 to May 2026. The most significant increases in cases were observed among individuals aged 15 to 24 years, particularly among adolescents, women, African Americans, and Native American populations.

Insights from CDC Researchers

Alana Vivolo-Kantor, the lead researcher from the CDC, noted the alarming rise in cases among adolescents and young adults. She remarked, «The initial premise was: ‘How is it possible that they have chronic use? Since when have they been consuming cannabis?'» This suggests a potential gap in understanding the consumption patterns among younger demographics.

Historical Context and Underdiagnosis

Experts believe that CHS has been historically underdiagnosed, often due to patients not disclosing their cannabis use or symptoms being misattributed to other medical conditions. This highlights the importance of increased awareness and education surrounding CHS.

Need for Further Research

The CDC report emphasizes the urgent need for expanded research into the effects of new cannabis products with high THC concentrations, such as vaporizers, beverages, and gummies, which have seen increased usage among young people in recent years. Greater awareness of this disorder could lead to improved early detection and treatment for those experiencing complications related to frequent cannabis consumption.